Repligen Corporation (RGEN): Price and Financial Metrics

RGEN POWR Grades

• RGEN scores best on the Sentiment dimension, with a Sentiment rank ahead of 85.7% of US stocks.
• The strongest trend for RGEN is in Momentum, which has been heading down over the past 179 days.
• RGEN ranks lowest in Momentum; there it ranks in the 14th percentile.

RGEN Stock Summary

• With a price/earnings ratio of 79.49, Repligen Corp P/E ratio is greater than that of about 91.2% of stocks in our set with positive earnings.
• The price/operating cash flow metric for Repligen Corp is higher than 94.37% of stocks in our set with a positive cash flow.
• With a price/sales ratio of 15.21, Repligen Corp has a higher such ratio than 90.67% of stocks in our set.
• Stocks that are quantitatively similar to RGEN, based on their financial statements, market capitalization, and price volatility, are MLAB, ICHR, LUNG, OMCL, and NVRO.
• RGEN's SEC filings can be seen here. And to visit Repligen Corp's official web site, go to www.repligen.com.

RGEN Valuation Summary

• RGEN's EV/EBIT ratio is 123.6; this is 321.84% higher than that of the median Healthcare stock.
• Over the past 243 months, RGEN's price/sales ratio has gone down 6.
• RGEN's price/earnings ratio has moved up 167.9 over the prior 243 months.

Below are key valuation metrics over time for RGEN.

RGEN Growth Metrics

The 2 year revenue growth rate now stands at 83.76%.
• The 3 year cash and equivalents growth rate now stands at 265.49%.
• Its 2 year net income to common stockholders growth rate is now at -19.35%.

Over the past 34 months, RGEN's revenue has gone up $460,698,000.

The table below shows RGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	670.534	119.016	128.291
2021-09-30	592.661	84.267	118.879
2021-06-30	508.505	83.273	99.933
2021-03-31	433.007	62.357	79.561
2020-12-31	366.26	62.625	59.926
2020-09-30	327.086	65.428	43.832

RGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RGEN has a Quality Grade of C, ranking ahead of 39.46% of graded US stocks.
• RGEN's asset turnover comes in at 0.293 -- ranking 157th of 682 Pharmaceutical Products stocks.
• ORMP, MESO, and AWH are the stocks whose asset turnover ratios are most correlated with RGEN.

The table below shows RGEN's key quality metrics over time.